Arkeon Biotechnologies Opens Pilot Production Facility to Bring CO2 Proteins to Market
Arkeon Biotechnologies, an Austrian startup converting CO2 into functional protein ingredients, announces it has achieved a significant milestone in its production process after successfully setting up a new pilot production plant. Located in Vienna’s Seestadt Innovation Hub, the new facility expands the company’s infrastructure with a 150L bioreactor system that, according to Arkeon, will improve its process and lay the biotechnological foundation for future large-scale production. Last year, Arkeon Biotechnologies unveiled …